Regen BioPharma (RGBPP) Asset Utilization Ratio (2016 - 2025)
Regen BioPharma (RGBPP) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.69 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio fell 41.53% to 0.69 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.69, a 41.53% decrease, with the full-year FY2025 number at 1.09, up 18.13% from a year prior.
- Asset Utilization Ratio was 0.69 for Q4 2025 at Regen BioPharma, down from 1.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.94 in Q1 2024 to a low of 2.57 in Q2 2022.
- A 5-year average of 0.36 and a median of 0.68 in 2021 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: tumbled 1950.37% in 2022, then soared 339.15% in 2024.
- Regen BioPharma's Asset Utilization Ratio stood at 1.77 in 2021, then surged by 120.92% to 0.37 in 2022, then soared by 234.66% to 1.24 in 2023, then decreased by 4.51% to 1.19 in 2024, then plummeted by 41.53% to 0.69 in 2025.
- Per Business Quant, the three most recent readings for RGBPP's Asset Utilization Ratio are 0.69 (Q4 2025), 1.0 (Q3 2025), and 1.29 (Q2 2025).